December 19, 2001

2 min read

Google Logo Add Us On GoogleAdd SciAm

Chemotherapy Can Cause Premature Aging in Cancer Cells

By Kate Wong

Join Our Community of Science Lovers!

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

Received wisdom about cancer holds that the only way to stop the disease is to kill the multiplying cells. Simply arresting cell division with drugs, scientists assumed, wouldn't work because the cells would eventually mend and resume proliferation. But new research, described in a report published yesterday in the early online edition of the Proceedings of the National Academy of Sciences, suggests that in fact many treated tumor cells that stop dividing do so permanently. The findings could point the way toward new anticancer drugs.

To assess the effects of chemotherapy on cancer cells that survive treatment, Igor Roninson of the University of Illinois and colleagues studied colon cancer cells that had been exposed to the drug doxorubicin. Surviving cells, the team found, look a lot like normal cells that have ceased growing as a result of old age, or senescence. Analyses of the molecular changes in the senescent cells revealed that the cells had activated a number of genes, about 10 of which can arrest cell growth. Some of these so-called tumor suppressor genes function in normal cells but turn off when the cell becomes cancerous. Drug-induced senescence appears to turn these genes back on, halting cell division.

Some drugs activate harmful genes, too, however. The treated colon cancer cells, for example, turned on genes known to stimulate the growth of surrounding cells. They also turned on the infamous p21 gene, which itself activates a number of genes linked to diseases associated with old age¿Alzheimer's among them. Other research indicates that this is not always the case, however. Roninson thus asserts that it should be possible to develop anticancer drugs that activate growth inhibitors associated with senescence without also inducing the harmful side effects.

Kate Wong is an award-winning science writer and senior editor for features at Scientific American, where she has focused on evolution, ecology, anthropology, archaeology, paleontology and animal behavior. She is fascinated by human origins, which she has covered for nearly 30 years. Recently she has become obsessed with birds. Her reporting has taken her to caves in France and Croatia that Neandertals once called home to the shores of Kenya’s Lake Turkana in search of the oldest stone tools in the world, as well as to Madagascar on an expedition to unearth ancient mammals and dinosaurs, the icy waters of Antarctica, where humpback whales feast on krill, and a “Big Day” race around the state of Connecticut to find as many bird species as possible in 24 hours. Wong is co-author, with Donald Johanson, of Lucy’s Legacy: The Quest for Human Origins. She holds a bachelor of science degree in biological anthropology and zoology from the University of Michigan. Follow her on Bluesky @katewong.bsky.social

More by Kate Wong

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe